Price T Rowe Associates Inc Fulgent Genetics, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 14,862 shares of FLGT stock, worth $305,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,862
Previous 14,261
4.21%
Holding current value
$305,414
Previous $310,000
5.81%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding FLGT
# of Institutions
195Shares Held
15.3MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$80.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$29.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.22MShares$25 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$19.7 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$17.1 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $622M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...